Whistleblowers allege problems with Wyeth's Prevnar
Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers' whistleblower suits accused the company of making false statements to the government concerning manufacturing problems with the vaccine.
Anthony Sokol, a manufacturing scientist, says he was fired after raising concerns regarding the vaccine and that Wyeth had concealed and misrepresented the data it gave to the government. Sokol's suit alleges he was fired in 2005. Prevnar earned $2.4 billion in sales last year.
- read the report from the Wall Street Journal
Related Article:
Pharma execs practice positive thinking. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
